NeoGenomics, Inc. (NEO)
NASDAQ: NEO · Real-Time Price · USD
8.32
+0.06 (0.73%)
May 14, 2026, 11:16 AM EDT - Market open
NeoGenomics Employees
NeoGenomics had 2,500 employees as of December 31, 2025. The number of employees increased by 300 or 13.64% compared to the previous year.
Employees
2,500
Change (1Y)
300
Growth (1Y)
13.64%
Revenue / Employee
$298,388
Profits / Employee
-$39,683
Market Cap
1.08B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 2,500 | 300 | 13.64% |
| Dec 31, 2024 | 2,200 | 100 | 4.76% |
| Dec 31, 2023 | 2,100 | 0 | - |
| Dec 31, 2022 | 2,100 | 100 | 5.00% |
| Dec 31, 2021 | 2,000 | 300 | 17.65% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Myriad Genetics | 2,700 |
| OPKO Health | 2,275 |
| Fulgent Genetics | 1,315 |
| GeneDx Holdings | 1,300 |
| Twist Bioscience | 979 |
| Castle Biosciences | 942 |
| GRAIL | 910 |
| CareDx | 765 |
NEO News
- 14 days ago - NeoGenomics price target lowered to $11 from $13 at BofA - TheFly
- 15 days ago - NeoGenomics price target raised to $14 from $13 at TD Cowen - TheFly
- 15 days ago - Leerink upgrades NeoGenomics to Outperform, raises target to $25 - TheFly
- 15 days ago - NeoGenomics upgraded to Buy from Hold at Benchmark - TheFly
- 15 days ago - NeoGenomics upgraded to Outperform from Market Perform at Leerink - TheFly
- 15 days ago - NeoGenomics reports Q1 adjusted EPS 1c, consensus 0c - TheFly
- 15 days ago - NeoGenomics raises FY26 revenue view to $797M-$803M from $793M-$801M - TheFly
- 15 days ago - NeoGenomics Earnings Call Transcript: Q1 2026 - Transcripts